secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK:        0000875320
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001193125-24-092475
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vertex to acquire Alpine Immune Sciences for $65 per share in all-cash tender offer
--------------------------------------------------------------------------------

- Vertex agrees to buy Alpine Immune Sciences at $65/share via tender offer followed by a merger.
- Supporting stockholders owning ~25.5% of Alpine shares have committed to tender their shares.
- Alpine must pay Vertex a $173M termination fee if deal terminates under specified conditions.
- Offer is not subject to a financing condition; expected to close by April 10, 2025 outside date.
- Deal includes full vesting of unvested equity awards, which will be cashed out at the offer price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875320/000119312524092475/0001193125-24-092475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875320/000119312524092475/d752930d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-092475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer